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yet been fully met in Belgium. Despite the success of the policy, adjustments are
desirable, especially with respect to the broad definition of cheap medicines. Given
the fact that all groups of physicians reached their minimum quota quite easily
together with the increased possibility of prescribing cheap medicines due to the
entrance of new, generic medicines, the government decided to raise the minimum
criteria in 2011.
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OBJECTIVES: To analyze state funding sources of drug provision all over RF for the
period of 2009-2010. METHODS: Different sources of drug funds were summed up
during this research. All materials were taken from the open sources: results of
auctions of the federal and regional level, orders of the Ministry of Public Health
and Social Development, analysis of regional programs of the drug provision and
etc. RESULTS: Interactive map of the RF was developed due to this analysis of the
collected data, it shows information on each region of the RF, the number of priv-
ileges people, population of the region, sum of the budget by the ONLS (reimburse-
ment) programs, the sum of the budget according to the regional reimbursement,
sum of the hospital budgets, sum of the special programs of the region (if such
programs approved in the region), sum of the budget by the program “7 nosologies”
(special reimbursement program), with the detailed separation of the budget ac-
cording to the nosologies. Such map clearly demonstrates difference in the funding
system between regions. The ranges of color distinction by regions were put into
the map for more convenient usage, it allows visually demonstrate difference in
funding on the territory of the RF. Several pilot regions of the RF were chosen where
data was validated, this process showed complete conformity of the existing data
with the official budgets of the regions. CONCLUSIONS: Nowadays this research
represents unique product in acceptance of administrative decisions for the ad-
ministrators of health sector of the RF. Also for the further improvement of the
given analytical system it is necessary to adjust the collecting of the corresponding
data for 2011 and to analyze the budget of regions on the Federal Health Modern-
ization Program 2011-2012.
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OBJECTIVES:General public perceptions will affect on their behavior towards med-
icines. Therefore, this study aims to evaluate the general public perceptions to-
wards medicines in the state of Penang Malaysia. METHODS: A cross sectional
study using convenience sampling technique was used. Appropriate descriptive
and inferential statistics were used to find the differences among the respondents.
All data were analyzed at alpha value of 0.05. RESULTS: Seven hundred respon-
dents were successfully responded to the survey. More than one third of the re-
spondents 37% stated that they understand what is meant by conventional medi-
cines, whereas 18.6% understand traditional medicines and only 3% understand
what is meant by generic medicines. On the other hand, 36% see doctor once they
have minor illness and 30% prefer to go to get OTC drugs from the community
pharmacy. Furthermore, 62% believe that more expensive drugs are of better qual-
ity, and more than 50% believe that advertising affect on their perceived quality of
medicines as well as the country of the manufacturer affects on their selection of
the drugs. Previous experience, physician’s recommendations, pharmacist’s rec-
ommendations, friend’s recommendations, cost of the medicine and medical in-
surance coverage were the main factors that affect on their perceptions.
CONCLUSIONS: General public in Penang are very concerning about the medicine
chosen. General public education on various types of medicines is important to
correct misconceptions and give them the knowledge that they need to make an
informed decision. Hence, physicians, pharmacists and other health care providers
play vital roles in educating the general public about medicines.
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OBJECTIVES: Disease related malnutrition (DRM) is a frequent but often unrecog-
nised problem, even in the developed world. The objective of this study was to
estimate the burden of disease related malnutrition (BoDRM) in Europe.METHODS:
An Excel model was developed to estimate direct incremental health care costs and
health burden (including increased mortality and reduced quality of life) due to
DRM. The monetary value of the health burden was calculated by multiplying the
QALY loss with explicit or implicit (2x GDP/capita) cost effectiveness thresholds in
each country. Collection of input variables involved a wide spectrum of current
data sources: international databases, PubMed, congress abstracts, references
from published papers. Ten primary diseases were incorporated into the model:
stroke, breast cancer, COPD, dementia, depression, colorectal cancer, musculosk-
eletal disorders, head and neck cancer, coronary heart disease, chronic
pancreatitis. RESULTS: For the 835 million European citizens, the direct financial
BoDRM is over 31 billion EUR annually. The estimated annual health burden is
approximately 5.7 million life years or 9.1 million QALYs. The total monetary value
of the health and financial BoDRM is 306 billion EUR. The health burden in chronic
diseases is greater than in acute diseases, and is also greater than the financial
burden. In acute diseases, the financial burden is greater than the health burden.
CONCLUSIONS: In Europe, DRM is a considerable health and financial burden and
represents a significant contribution to the total burden of disease, estimated by
WHO to be 255 million DALYs annually. Therefore, there is a need to improve
nutritional care in all aspects of patient management. The availability of scientific
data on DRM is limited, especially regarding the relative mortality risk and quality
of life impact. Policy makers should support programmes to extend the clinical and
economic evidence base for nutritional care.
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OBJECTIVES:The inclusion of lost productivity costs in pharmacoeconomic studies
is still a subject of considerable debate. The aim of this study was to quantify the
work impairment due to general health status in population of employees and
employers (i.e. owners and managers). METHODS: Data were obtained from a sur-
vey that incorporated the WPAI-GH questionnaire and questions on costs of worker
replacement (including hiring and training process). The survey was conducted in
cooperation with Employers of Poland – the largest and oldest organisation of
employers in Poland in the framework of research grant no N N405 115034 offered
by the Ministry of Science and Higher Education of the Republic of Poland.
RESULTS: The non-representative population comprised 196 subjects in paid jobs
(156 employees and 40 employers), 167 of whom were currently employed in gov-
ernment-owned corporations (with 250 employees). Employees reported 7.4% of
work time missed due to health problems (absenteeism) during the past 7 days
(0.8% for employers; p0.052). Impairment while being at work (presenteeism)
amounted to 12.2% of total time for employers (5.4% for employers; p0,05). Per-
centage of overall work impairment due to health problems for employees and
employers were 5.7% vs. 18.3%, respectively (p0.05). On average more than 50% of
overall work impairment was compensated by other employees in the company
with a general tendency of a higher compensation of employees’ responsibilities.
Mean time of hiring and training new worker to achieve 50% of expected produc-
tivity was 76 days and 216 days to achieve full productivity. CONCLUSIONS: Pro-
ductivity loss measured by WPAI-GH is higher among employees than employers
in analyzed sample in Poland, with a tendency of a higher compensation among
employees. Preliminary data suggest that overall work impairment can be com-
pletely compensated within a one year from a single employer perspective and
support friction cost approach.
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OBJECTIVES: An automated dose dispensing (ADD) service is implemented in pri-
mary health care in some countries, particularly in the Nordic countries. In this
service, regularly used medicines are machine-packed into unit-dose bags for each
point of administration. The aim of this study is to review the evidence of the ADD’s
influence on the appropriateness of medication use, medication safety and costs in
the primary health care.METHODS:A literature search was performed on the most
relevant databases, including the Medline, Embase, and Cochrane Library. An ar-
ticle was included in the review if the study was conducted in primary health care
or nursing home settings and medicines were dispensed in unit-dose bags. All
study designs were approved and control groups were not required. Studies apply-
ing outcome measures that were related to the appropriateness of medication use,
medication safety or costs were included. RESULTS: Out of 278 abstracts, six stud-
ies were found to be acceptable. The prevalencies of potential inappropriate drug
use (IDU) were higher among ADD users than non-ADD users. After controlling for
confounding factors, ADD reduced the probability of long-acting benzodiazepine
use among women and drug-drug interactions among women and men. The ADD
users aged 65-79 years had more problems with potential IDU than older ones
(80 years). The risk of administration errors was lower if medicines were supplied
by the ADD service. The ADD service also reduced discrepancies in the documen-
tation of patient medication records. Any costs were not investigated in the
studies. CONCLUSIONS: The evidence of the influence of ADD on appropriateness
of medication use and medication safety is limited, and missing on costs. The
findings of this review suggest that the ADD service may improve medication
safety in primary health care, but does not effectively reduce potential IDU.
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OBJECTIVES: To evaluate the feasibility of the C.A.T-Health system (a computer-
ized adaptive test which evaluates generic Health-Related Quality of Life-HRQoL) in
a university hospital, at different levels of the health care process. METHODS: The
C.A.T-Health system has been developed and validated within a 3 years research
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